227 related articles for article (PubMed ID: 35128573)
21. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
22. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Spironolactone Solid Dispersions Prepared by Co-Spray Drying With Soluplus
Al-Zoubi N; Odah F; Obeidat W; Al-Jaberi A; Partheniadis I; Nikolakakis I
J Pharm Sci; 2018 Sep; 107(9):2385-2398. PubMed ID: 29752945
[TBL] [Abstract][Full Text] [Related]
24. Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis.
Khattab A; Hassanin L; Zaki N
AAPS PharmSciTech; 2017 Jul; 18(5):1657-1672. PubMed ID: 27677262
[TBL] [Abstract][Full Text] [Related]
25. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus® by spray drying technique.
Ha ES; Baek IH; Cho W; Hwang SJ; Kim MS
Chem Pharm Bull (Tokyo); 2014; 62(6):545-51. PubMed ID: 24881660
[TBL] [Abstract][Full Text] [Related]
27. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
[TBL] [Abstract][Full Text] [Related]
28. Preparation, in-vitro and in-vivo characterisation of CoQ10 microparticles: electrospraying-enhanced bioavailability.
Fung WY; Liong MT; Yuen KH
J Pharm Pharmacol; 2016 Feb; 68(2):159-69. PubMed ID: 26730452
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of coenzyme Q10-Eudragit solid dispersion.
Nazzal S; Guven N; Reddy IK; Khan MA
Drug Dev Ind Pharm; 2002 Jan; 28(1):49-57. PubMed ID: 11858524
[TBL] [Abstract][Full Text] [Related]
30. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
31. A Comparative Solubility Enhancement Study of Cefixime Trihydrate Using Different Dispersion Techniques.
Obaidat RM; Khanfar M; Ghanma R
AAPS PharmSciTech; 2019 May; 20(5):194. PubMed ID: 31119496
[TBL] [Abstract][Full Text] [Related]
32. Biopharmaceutical characterization of nanocrystalline solid dispersion of coenzyme Q10 prepared with cold wet-milling system.
Onoue S; Terasawa N; Nakamura T; Yuminoki K; Hashimoto N; Yamada S
Eur J Pharm Sci; 2014 Mar; 53():118-25. PubMed ID: 24368114
[TBL] [Abstract][Full Text] [Related]
33. Pseudorotaxane-like supramolecular complex of coenzyme Q10 with gamma-cyclodextrin formed by solubility method.
Nishimura K; Higashi T; Yoshimatsu A; Hirayama F; Uekama K; Arima H
Chem Pharm Bull (Tokyo); 2008 May; 56(5):701-6. PubMed ID: 18451562
[TBL] [Abstract][Full Text] [Related]
34. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.
Hatanaka J; Kimura Y; Lai-Fu Z; Onoue S; Yamada S
Int J Pharm; 2008 Nov; 363(1-2):112-7. PubMed ID: 18706989
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Inclusion Complex of Coenzyme Q10 with the New Carrier CD-MOF-1 Prepared by Solvent Evaporation.
Inoue Y; Nanri A; Murata I; Kanamoto I
AAPS PharmSciTech; 2018 Oct; 19(7):3048-3056. PubMed ID: 30088151
[TBL] [Abstract][Full Text] [Related]
37. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®.
Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G
Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068
[TBL] [Abstract][Full Text] [Related]
38. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
[TBL] [Abstract][Full Text] [Related]
40. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
